The present invention provides a compound represented by the formula:
wherein R
1
is an acyl group, R
2
is a hydrocarbon group which may be substituted or the like, R
3
is a hydrocarbon group which may be substituted or the like, R
4
is a hydrocarbon group which may be substituted or the like, n is from 0 to 4, and X is an oxygen atom, a sulfur atom or the like, or a salt thereof. The invention also provides a compound which has a TGR23 antagonist activity and thus is useful for prevention and treatment of cancer.
Pd(II)-catalyzed enantioselective C—H arylation of free carboxylic acids
申请人:The Scripps Research Institute
公开号:US11021427B2
公开(公告)日:2021-06-01
The invention includes procedures for stereoselective β-acylation of carboxylic acids having a β-carbon atom. For example, stereoselective acylation procedures include the following reactions: (I)
TUBASHEVA, I. A., MATER. 5 KONF. MOL. UCHEN. I SPETS. MOSK. IN-TA TONK. XIM. TEXNOL., MOSKV+
作者:TUBASHEVA, I. A.
DOI:——
日期:——
PD(II)-CATALYZED ENANTIOSELECTIVE C-H ARYLATION OF FREE CARBOXYLIC ACIDS
申请人:The Scripps Research Institute
公开号:US20210087131A1
公开(公告)日:2021-03-25
The invention includes procedures for stereoselective β-acylation of carboxylic acids having a β-carbon atom. For example, stereoselective acylation procedures include the following reactions: (I)